A previous study demonstrated that IL-7 signaling blockade using anti-IL-7Rα monoclonal antibody (mAb) treatment or endothelial-specific deletion of IL-7Rα attenuates psoriasis-like skin inflammation mediated by infiltration of T cells and DCs into the inflamed lesion [17]. Here, IL7R is linked to psoriasis.